CLS_B fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Clinical Laserthermia Systems AB engages in the development and manufacture of pharmaceutical products. It offers TRANBERG, a Thermal Therapy System and specially designed sterile disposable products for safe, gentle and effective treatment of cancerous tumors that is marketed for image-guided laser ablation and for treatment with immuno-stimulating interstitial laser thermotherapy. The company was founded by Karl-Göran Tranberg, Lars-Erik Thomas Eriksson, and Per-Hakan Henriksson on March 9, 2006 and is headquartered in Lund, Sweden.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
CLS_B does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company